Business Wire

DENTAL-MONITORING/LOUM

Share
Dental Monitoring strengthens its leading position in AI-powered tele dentistry by acquiring Loum, a European health tech start-up

Dental Monitoring has acquired Loum, "the digital assistant for patients and healthcare professionals.” Founded in 2017, Loum's objective is to ensure that patients perceive their healthcare positively, and not as a burden. Their innovative developments, in particular an application designed to improve the patient experience, complements Dental Monitoring’s expansive suite of AI-driven tools. The app implements a playful and dynamic system that facilitates the doctor-patient relationship and allows patients to engage fully with their treatment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200505005871/en/

"We are delighted with the acquisition of Loum, which allows us to integrate complementary skills into our teams and meet the expectations of patients and their doctors worldwide. We are coordinating a robust solution and collaborating with a team of skilled colleagues who will enhance our AI-powered platform with new strategies and an innovative approach. Ultimately, we want to design a more playful version of our patient application, and through Loum’s gamification approach, which allows for careful monitoring of treatment, this is an angle that we are now addressing," says Philippe Salah, CEO of the Dental Monitoring.

"Placing gaming at the heart of the healthcare protocol not only brings a little lightness to the patient’s journey, but also makes any follow-up care much more appealing, accessible, and more likely to be followed,” explains Michaël Sutter, CEO of Loum.

"Joining Dental Monitoring is great news for us and our customers. We now offer them the possibility of benefitting from a broader range of cutting-edge solutions for the management of their patients’ care, while continuing to provide them with personalized and local support. This integration is also an accelerator in terms of innovation and is therefore in line with a product offering that remains at the forefront of market expectations. We are delighted to bring our vision of the patient journey and to partner with those who share our taste for service and excellence," announced Michaël Sutter, CEO, and Clément Coicault, COO of Loum.

###

About Dental Monitoring:

Founded in 2015 by Philippe Salah, Dental Monitoring is the first AI-based company to target dental professionals and improve the care they provide their patients.

Dental Monitoring solutions are created to assist dental professionals throughout their patients’ journeys by:

● Simplifying the connection between dental professionals and patients

● Facilitating follow-ups and providing an easier virtual experience during treatment

● Improving treatment stability and results over time

Dental Monitoring is present across Europe, the United States and Asia Pacific. It has 250 employees and 5 offices (Paris, Austin - Texas, London, Hong Kong and Sydney).

Dental Monitoring is changing the way dental and orthodontic professionals care for patients. If you would like more information about Loum and this acquisition, or about the Dental Monitoring’s full suite of tele dentistry solutions, please visit www.dental-monitoring.com .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Quectel Launches RG660QA and RG660QB 5G Modules With Advanced Performance Features7.1.2026 18:00:00 CET | Press release

Quectel Wireless Solutions, an end-to-end global IoT solutions provider, today announces the launch of the RG600QA and RG660QB 5G module, based on the Qualcomm® X85 and X82 5G Modem-RF Systems. The RG660QA is based on X85 while the RG660QB is based onX82. Engineering samples of two first SKUs in the RG660Qx series have been already made available to customers and pre-production samples will be available to the market in Q2 2026. Designed for versatility, this module series supports a broad array of next generation 5G use cases, from home and business wireless broadband to mobile video, camera applications, and high-performance mobile hotspots. In indoor 5G CPE, it unlocks premium performance by enabling Wi-Fi 7 across the 2.4 GHz, 5 GHz, and 6 GHz bands, with integrated Bluetooth to support a full ecosystem of connected devices. With Ethernet speeds reaching up to 10 Gbps, the RG660Qx delivers the high-capacity backbone needed to power ultra-fast, reliable home and enterprise networks.

Sodali & Co Announces Executive Leadership Appointments7.1.2026 17:00:00 CET | Press release

Accelerates Firm Strategy to Deliver Global Integrated Stakeholder Solutions Sodali & Co (the ‘firm’ or ‘Sodali’), the leading global capital markets-centric stakeholder advisory firm, is pleased to announce four appointments to its Executive Leadership Team (ELT) under Chief Executive Officer Andrew Benett. These newly created senior roles will strengthen Sodali’s ability to respond to clients’ evolving needs with an integrated suite of shareholder, sustainability, and strategic communications advisory services delivered on a global scale. The appointments are as follows: Brett Clegg has been promoted to Chief Commercial Officer. Brett was previously Chairman of Sodali’s APAC region, based in the firm’s Sydney office. He specializes in advising clients on strategic communications, issues management, and capital markets transactions. Prior to Sodali, Brett spent over two decades in senior executive and editorial roles at some of Australia’s leading news brands, including The Australian

1NCE Continues Growth and Expands Its Software, AI and Services Offering7.1.2026 14:15:00 CET | Press release

In 2025 1NCE added another 10 million endpoints to its foundational IoT platform; now manages 40+ million intelligent products for 30,000 customers in 17 industries. Introduces new software, 1NCE Insights, the AI + IoT fusion of intelligence from its network that gives analytics and benchmark data on how customers can better setup, manage and optimize their device estates. 1NCE, a company offering a plug-and-play platform for creating and managing the world’s best IoT products, reports another strong growth year, adding another 10 million endpoints. The company now manages 40+ million intelligent products for 30,000+ customers across 17 industries. 1NCE’s software and connectivity platform has become a new industry standard, delivering hassle-free IoT in 170+ countries and regions. The company has a unique vantage point in the IoT ecosystem, with four billion data records per day collected through 250+ streams on the world’s largest IoT network in the cloud. The company launched a new

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking7.1.2026 14:00:00 CET | Press release

Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, Prudentia accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams. The company’s human-in-the-loop approach orchestrates seamless collaboration between buyers, sellers, and intermediaries. This ensures a secure, compliant infrastructure

Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release

FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye